[HTML][HTML] Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study

…, JM Pescarini, JB Júnior, TM Machado… - The Lancet Regional …, 2022 - thelancet.com
Background Aging influences COVID-19 severity and response to vaccination, but previous
vaccine effectiveness (VE) analyzes lack the power to evaluate its role in subgroups within …

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26. COV2. S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative …

…, ES Paixão, JB Júnior, TM Machado… - The Lancet Infectious …, 2022 - thelancet.com
Background COVID-19 vaccines have proven highly effective among individuals without a
previous SARS-CoV-2 infection, but their effectiveness in preventing symptomatic infection …

[HTML][HTML] CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study

…, T Cerqueira-Silva, JB Júnior, TM Machado… - BMC medicine, 2022 - Springer
Background More doses of CoronaVac have been administered worldwide than any other
COVID-19 vaccine. However, the effectiveness of COVID-19 inactivated vaccines in pregnant …

Improving author name disambiguation with user relevance feedback.

AA Ferreira, TM Machado, MA Gonçalves - 2012 - repositorio.ufop.br
Author name ambiguity in the context of bibliographic citations is a very hard problem. It
occurs when there are citation records of a same author under distinct names or when there …

[HTML][HTML] The effectiveness of Vaxzevria and CoronaVac vaccines: A nationwide longitudinal retrospective study of 61 million Brazilians (VigiVac-COVID19)

…, J Pescarini, JB Júnior, TM Machado… - MedRxiv, 2021 - medrxiv.org
Background High rates of virus transmission and the presence of variants of concern can
affect vaccine effectiveness (VE). Both conditions occur in low-income countries, which …

Syndromic detection of upper respiratory infections in primary healthcare as a candidate for COVID-19 early warning in Brazil: a retrospective ecological study

…, R Flores-Ortiz, TM Machado… - Available at SSRN …, 2023 - papers.ssrn.com
Background: Syndromic Surveillance of mild cases of respiratory viruses are a valuable tool
for public health, able to warn health authorities of the onset of an outbreak 2 to 4 weeks …

Effectiveness of the CoronaVac vaccine in prevention of symptomatic and progression to severe COVID-19 in pregnant women in Brazil

…, T Cerqueira-Silva, JB Júnior, TM Machado… - 2021 - papers.ssrn.com
Background: The effectiveness of Covid-19 inactivated vaccines in pregnant women is
unknown. We estimated vaccine effectiveness (VE) of CoronaVac against symptomatic and …

[HTML][HTML] Desenvolvimento e avaliação de uma plataforma colaborativa digital para educação e tomada de decisão médica baseada em evidências

ÁO Santos, A Sztajnberg, TM Machado… - Revista brasileira de …, 2020 - SciELO Brasil
The medical education for clinical decision-making has undergone changes in recent years.
Previously supported by printed material, problem solving in clinical practice has recently …

Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26. COV2. S among individuals with prior SARS-CoV-2 infection in Brazil (preprint)

…, ES Paixao, J Bertoldo Jr, TM Machado… - 2021 - pesquisa.bvsalud.org
Background. COVID-19 vaccines have proven highly effective among SARS-CoV-2 naive
individuals, but their effectiveness in preventing symptomatic infection and severe outcomes …

The effectiveness of Vaxzevria and CoronaVac vaccines: A nationwide longitudinal retrospective study of 61 million Brazilians (VigiVac-COVID19)

…, J Pescarini, J Bertoldo Júnior, TM Machado… - 2021 - arca.fiocruz.br
High rates of «virus»«transmission» and the presence of variants of concern can «affect»«vaccine»«effectiveness»(VE).
Both conditions occur in low-«income» countries, which …